LUCY — Innovative Eyewear Share Price
Last trade - 00:00- $4.27m
- -$3.26m
- $1.64m
- 41
- 47
- 19
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.47 | ||
| Price to Tang. Book | 0.49 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.61 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -87.06% | ||
| Return on Equity | -106% | ||
| Operating Margin | -484.2% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.06 | 0.69 | 0.66 | 1.15 | 1.64 | 10.3 | 25.6 | 220.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 26th, 2020
- Public Since
- August 12th, 2022
- No. of Shareholders
- 3,775
- No. of Employees
- 11
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 2,452,632
- Address
- 11900 Biscayne Blvd, Ste 630, MIAMI, 33181
- Web
- https://lucyd.co/
- Phone
- +1 7869101898
- Auditors
- Cherry Bekaert LLP
Upcoming Events for LUCY
Similar to LUCY
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
As of Today at 21:18 UTC, shares in Innovative Eyewear are trading at $1.74. This share price information is delayed by 15 minutes.
Shares in Innovative Eyewear last closed at $1.74 and the price had moved by -66.53% over the past 365 days. In terms of relative price strength the Innovative Eyewear share price has underperformed the S&P500 Index by -68.52% over the past year.
The overall consensus recommendation for Innovative Eyewear is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInnovative Eyewear does not currently pay a dividend.
Innovative Eyewear does not currently pay a dividend.
Innovative Eyewear does not currently pay a dividend.
To buy shares in Innovative Eyewear you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.74, shares in Innovative Eyewear had a market capitalisation of $4.27m.
Here are the trading details for Innovative Eyewear:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: LUCY
Based on an overall assessment of its quality, value and momentum Innovative Eyewear is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Innovative Eyewear is $9.00. That is 417.24% above the last closing price of $1.74.
Analysts covering Innovative Eyewear currently have a consensus Earnings Per Share (EPS) forecast of -$2.40 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovative Eyewear. Over the past six months, its share price has underperformed the S&P500 Index by -71.35%.
As of the last closing price of $1.74, shares in Innovative Eyewear were trading -68.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovative Eyewear PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.74.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Innovative Eyewear's directors